ANXA5 and acute myeloid leukemia: TMIGD2 knockdown resulted in increased expression of differentiation marker CD11b and apoptotic marker annexin V in primary AML cells but not in NBM and CBU (Fig. 5b, c and Supplementary Fig. 5a), indicating that TMIGD2 is specifically important for LSCs.